To study the outcome and causes of an eye disease which results in increased pressure in eye

Not yet recruiting

• Conditions: Glaucoma secondary to other eye disorders,

• Registration Number: CTRI/2021/01/030467
• Lead Sponsor: Aravind Eye Hospital Pondicherry

Brief Summary

**Aim:**

Toassess the clinical and demographic profile of patients presenting withneovascular glaucoma at a tertiary eye care centre and to assess the prognosticfactors.

**Objectives**

Primary Objectives

1 To analyse the variousetiologies leading to NVG.

Secondaryobjectives

1 To assess the risk factors and prognostic variables in the study population.

2 To assess therelationship between the various patient characteristics in neovascularglaucoma with the outcome

**ExpectedOutcome**

Weexpect that studying the clinical profile of NVG patients will help us in betterunderstanding of NVG and understand the reasons for delayed presentation or poorfollow up which can help in formulating follow up protocols for earlydetection and modify counselling techniques to improve follow ups and impartknowledge about the risk factors to the patients

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-25
• Last Update Posted: 2021-06-01

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

Newly diagnosed patients of NVG fitting into the diagnosis of NVG Visual acuity of even no light light perception at presentation Patients who have been treated earlier for primary cause like diabetic retinopathy(DR) central retinal vein occlusion (CRVO) or Ocular Ischaemic syndrome.

Exclusion Criteria

Patients with physical disability or mental or psychological ailments where ocular examination and follow ups would be difficult Patients treated previously for NVG.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We expect that studying the clinical profile of NVG patients will help us in better understanding of NVG and understand the reasons for delayed presentation or poor follow up which can help in formulating follow up protocols for early detection and modify counselling techniques to improve follow ups and impart knowledge about the risk factors to the patients	At 3 months

Trial Locations

Locations (1)

Aravind Eye Hospital Pondicherry; 🇮🇳 Pondicherry, PONDICHERRY, India

Aravind Eye Hospital Pondicherry

🇮🇳Pondicherry, PONDICHERRY, India

Dr Shalini S Nair

Principal investigator

8281912599

shalini.s@aravind.org